C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Name: C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
SKU: 3369
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 1 Articles Tags: c-lindsay-devane, dosage-regimen-design, heidi-l-liston, medworks-media, pharmacokinetics, psychopharmacology, psychopharmacology-bulletin, second-dose-effect

Description

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Assessment of Anxiety in Clinical Trials with Depressed Patients

Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Related products

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Assessment of Anxiety in Clinical Trials with Depressed Patients

Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki